RBC
ELAN icon

Roble Belko & Company’s Elanco Animal Health ELAN Stock Holding History

Roble Belko & Company’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-85
Closed – – 348
2021
Q3 		$0 Hold
85
– – ﹤0.01% 326
2021
Q2 		$0 Hold
85
– – ﹤0.01% 330
2021
Q1 		$0 Hold
85
– – ﹤0.01% 325
2020
Q4 		$0 Buy
+85
New +$2.59K ﹤0.01% 312
2019
Q3 		– Sell
-10
Closed – – 339
2019
Q2 		$0 Buy
+10
New +$325 ﹤0.01% 349

Other funds holding ELAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Roble Belko & Company's ELAN Position: Q4 2021 in Review

Roble Belko & Company sold out of Elanco Animal Health (ELAN) in Q4 2021, closing a stake of 85 shares.

Roble Belko & Company first reported a position in ELAN in Q2 2019 and held it in 5 quarters. The position peaked at $0 in Q3 2021. 480 funds tracked by Wall St. Rank hold ELAN as of Q4 2021.

  • Roble Belko & Company reported no remaining Elanco Animal Health position as of Q4 2021 after selling out during the quarter.
  • Roble Belko & Company sold 85 Elanco Animal Health shares in Q4 2021.
  • Roble Belko & Company first reported a position in Elanco Animal Health in Q2 2019 and held it in 5 quarters.
  • Roble Belko & Company's Elanco Animal Health position peaked at $0 in Q3 2021.
  • 480 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2021.

Based on Roble Belko & Company's 13F filing for Q4 2021, filed 7 Feb 2022.